Caption Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,000
Closed -$216K 1597
2023
Q2
$216K Sell
25,000
-25,000
-50% -$224K ﹤0.01% 924
2023
Q1
$452K Buy
+50,000
New +$436K 0.01% 808
2021
Q1
Sell
-100,000
Closed -$4.73M 1447
2020
Q4
$4.73M Buy
100,000
+75,000
+300% +$3.48M 0.11% 237
2020
Q3
$1.16M Buy
+25,000
New +$858K 0.03% 586
2020
Q2
Sell
-16,400
Closed -$581K 1214
2020
Q1
$581K Buy
+16,400
New +$671K 0.03% 512

Other funds holding ZYME

Caption Management's ZYME Position: Q4 2021 in Review

Caption Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 8,200 shares — an estimated $238K sold.

Caption Management first reported a position in ZYME in Q3 2021 and held it in 1 quarter. The position peaked at $238K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

  • Caption Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 8,200 Zymeworks shares in Q4 2021, an estimated $238K.
  • Caption Management first reported a position in Zymeworks in Q3 2021 and held it in 1 quarter.
  • Caption Management's Zymeworks position peaked at $238K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.